Back
Keros Therapeutics, Inc. Vs. NovaBay Pharmaceuticals, Inc. Industry Stock Comparison
Buy
54
KROS
Keros Therapeutics, Inc.
Last Price:
$20.47
Seasonality Move:
4.91%
Buy
70
NBY
NovaBay Pharmaceuticals, Inc.
Last Price:
$4.73
Seasonality Move:
10.47%
Buy
54
Keros Therapeutics, Inc. (KROS)
is a Buy
Is Keros Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Keros Therapeutics, Inc. [KROS] share price is $20.63. The Score for KROS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
KROS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
NovaBay Pharmaceuticals, Inc. (NBY)
is a Buy
Is NovaBay Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals, Inc. [NBY] share price is $4.86. The Score for NBY is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
NBY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KROS Stock Price Chart
What is Keros Therapeutics, Inc.'s stock price today?
-
The Keros Therapeutics, Inc. share price today is $20.63The current trend is moderately bullish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals, Inc.'s stock price today?
-
The NovaBay Pharmaceuticals, Inc. share price today is $4.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.89 | Buy |
| Relative Strength Index (14 RSI): | 57.05 | Buy |
| Chaikin Money Flow: | -192087 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.1 - 21.78) | Buy |
| Bollinger Bands (100): | (14.31 - 18.87) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.99 | Buy |
| Relative Strength Index (14 RSI): | 72.71 | Buy |
| Chaikin Money Flow: | 315548 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.98 - 4.12) | Buy |
| Bollinger Bands (100): | (0.62 - 2.84) | Buy |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.87 | Sell |
| 20-day SMA: | 20.58 | Buy |
| 50-day SMA: | 17.94 | Buy |
| 200-day SMA: | 15 | Buy |
| 8-day EMA: | 20.95 | Sell |
| 20-day EMA: | 20.33 | Buy |
| 50-day EMA: | 18.66 | Buy |
| 200-day EMA: | 18.79 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.53 | Buy |
| 20-day SMA: | 2.95 | Buy |
| 50-day SMA: | 1.84 | Buy |
| 200-day SMA: | 1.16 | Buy |
| 8-day EMA: | 4.41 | Buy |
| 20-day EMA: | 3.36 | Buy |
| 50-day EMA: | 2.2 | Buy |
| 200-day EMA: | 0.87 | Buy |
Keros Therapeutics, Inc. Earnings Growth & KROS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.45 per share, and a decrease next year of $5.27 per share.
NovaBay Pharmaceuticals, Inc. Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.
Keros Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||